Metsera, Inc. (NASDAQ:MTSR – Get Free Report)’s stock price traded down 6% during mid-day trading on Thursday . The stock traded as low as $29.20 and last traded at $29.74. 329,691 shares were traded during mid-day trading, a decline of 50% from the average session volume of 657,366 shares. The stock had previously closed at $31.65.
Metsera Trading Up 1.8 %
About Metsera
Metsera, Inc is a clinical stage biopharmaceutical company, which engages in the development of a next-generation injectable and oral nutrient stimulated hormone, or NuSH, analog peptides to treat obesity, overweight and related conditions. Its product pipeline includes MET-097i, MET-233, and MET-224o.
Further Reading
- Five stocks we like better than Metsera
- How to Profit From Growth Investing
- Roblox’s Big Dip: A Chance to Get in on the Vaunted Gaming Stock?
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- 3 Dividend ETFs to Capitalize on the Slide in Chip Stocks
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Is Chevron Stock Primed for Growth After Profit-Boosting News?
Receive News & Ratings for Metsera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metsera and related companies with MarketBeat.com's FREE daily email newsletter.
